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Cues (conditioned stimuli; CSs) associated with rewards can come to motivate 
behavior, but there is considerable individual variation in their ability to do so. For 
example, a lever-CS that predicts food reward becomes attractive, wanted, and elicits 
reward-seeking behavior to a greater extent in some rats (“sign-trackers”; STs), than 
others (“goal-trackers”; GTs). Variation in dopamine (DA) neurotransmission in the 
nucleus accumbens (NAc) core is thought to contribute to such individual variation. 
Given that the DA transporter (DAT) exerts powerful regulation over DA signaling, 
we characterized the expression and function of the DAT in the accumbens of STs and 
GTs. STs showed greater DAT surface expression in ventral striatal synaptosomes than 
GTs, and ex vivo fast-scan cyclic voltammetry recordings of electrically-evoked DA 
release confirmed enhanced DAT function in STs, as indicated by faster DA uptake, 
specifically in the NAc core. Consistent with this, systemic amphetamine (AMPH) 
produced greater inhibition of DA uptake in STs than in GTs. Furthermore, injection of 
AMPH directly into the NAc core enhanced lever-directed approach in STs, presumably 
by amplifying the incentive value of the CS, but had no effect on goal tracking behavior. 
On the other hand, there were no differences between STs and GTs in electrically-
evoked DA release in slices, or in total ventral striatal DA content. We conclude that 
greater DAT surface expression may facilitate the attribution of incentive salience to 
discrete reward cues. Investigating this variability in animal sub-populations may help 
explain why some people abuse drugs, while others do not. 
 
Introduction 
People with substance abuse disorders show an attentional bias towards drug 
cues (conditioned stimuli, CSs), and such cues acquire strong motivational control over 
behavior (Thewissen et al., 2007; Field et al., 2008; Franklin et al., 2011). Individual 
variation in the propensity to attribute motivational value (incentive salience) to reward 
cues can be studied in animals using a Pavlovian Conditioned Approach (PCA) 
procedure. Some rats, “sign-trackers” (STs) are attracted to reward cues to a much 
greater extent than others (“goal-trackers”, GTs), which instead direct their responding 
toward the location of reward delivery (Flagel et al., 2009; Robinson et al., 2014). In 
addition, reward cues function as more effective conditioned reinforcers (Robinson & 
Flagel, 2009) and are more effective in instigating reward-seeking behavior (Yager & 
Robinson, 2012; Yager et al., 2015) in STs than GTs. Importantly, these different 
behavioral responses to food-associated cues predict the extent to which drug cues 
come to motivate approach and drug-seeking behavior (Saunders & Robinson, 2012; 
Yager et al., 2015).   
Dopamine (DA) neurotransmission, especially in the core of the nucleus 
accumbens (NAc), is known to be important in conferring motivational properties to 
reward cues (Robinson & Berridge, 1993; Cardinal et al., 2002). In both humans and non-
human animals, food- or drug-related stimuli evoke DA release in the NAc (Boileau et 
al., 2007; Day et al., 2007; Flagel et al., 2011; Fotros et al., 2013), and, reward cues are more 
effective in evoking DA release in the NAc core in STs than GTs (Flagel et al., 2011). 
Although differential rates of spontaneous DA release events have been documented in 
selectively bred lines of rats that either sign- or goal-track (Flagel et al., 2010), this has 
not been described in outbred STs and GTs. However, both systemic and intra-
accumbens injections of DA antagonists disrupt ST conditioned responses (CRs) to a 
greater extent than GT CRs (Danna & Elmer, 2010; Flagel et al., 2011; Saunders & 
Robinson, 2012; Saunders et al., 2013; Yager et al., 2015), and enhancing DA release 
increases sign-tracking, but not goal-tracking, behavior (Danna et al., 2013).   
Amphetamine (AMPH) also augments the motivational value of CSs (Taylor & 
Robbins, 1984; Kelley & Delfs, 1991; Fletcher et al., 1998; Wyvell & Berridge, 2000; Peciña 
& Berridge, 2013). Interestingly, AMPH given directly into the NAc core selectively 
reinstates cue-induced drug seeking in STs (Saunders et al., 2013). AMPH is thought to 
exert effects on motivated behavior primarily by increasing DA release, in part due to 
reversal of the DA transporter (DAT; Giros et al., 1996). It is possible, therefore, that 
differential levels of DAT expression and/or function contribute to the greater effect of 
AMPH in STs compared to GTs (Saunders et al., 2013). Thus, we sought to characterize 
the expression and function of the DAT in rats that vary in their propensity to attribute 
incentive salience to reward cues. 
 
Materials & Methods 
Subjects & Pavlovian Training 
Outbred male Sprague-Dawley rats (n=99; from both Harlan & Charles River 
Laboratories) were either housed individually (Exp. 3) or housed in pairs (Exp. 1-2) in a 
temperature- and humidity-controlled vivarium with a reverse light cycle. Food and 
water were available ad libitum. Starting 1-week after arrival, all procedures were 
performed during the dark phase of the light cycle. 
Pavlovian training used operant chambers and procedures described previously 
(Saunders & Robinson, 2012). Briefly, conditioning (5 days) consisted of 25 CS-US 
pairings/day on a variable time 90s schedule. Each CS presentation (extension and 
illumination of a lever) lasted for 8s. Retraction of the lever was followed immediately 
by delivery of 1 banana-flavored pellet (US) into the food cup. The degree to which rats 
displayed lever (ST) or food cup (GT) directed behavior was quantified using a PCA 
index, as described previously (Meyer et al., 2012; Saunders & Robinson, 2012). Factors 
included in the index consisted of (1) response probability [P(lever) – P(food cup)], (2) response 
bias [(lever deflections – food cup entries) / (lever deflections + food cup entries)], and 
(3) the latency [(lever deflection latency – food cup entry latency) / 8] for making either 
a lever-directed or food cup-directed CR during the CS. The PCA index was calculated 
from the average of their Day 4 and Day 5 data according to the following formula: 
[(probability difference + response bias + latency score) / 3]. Based on this index, STs 
were defined as animals that had a score ranging from +0.4 to 1.0. In contrast, GTs had a 
score ranging from -1.0 to -0.4. Although rats with Intermediate scores (INs) were 
classified (PCA score -0.4 to +0.4), they were not used in the present experiments 
because we wanted to concentrate on differential neurochemistry between rats that 
varied markedly in their propensity to attribute incentive salience to the lever-CS (i.e., 
STs vs GTs). All procedures were conducted according to a protocol approved by the 
University of Michigan Committee on Use and Care of Animals (UCUCA). 
 
Experiment 1: Presynaptic Regulation of DA Signaling in the NAc core 
Stimulated DA Release in Brain Slices 
 A subset of rats (ST, n=6; GT, n=5) were left undisturbed in their home cages for 
~2-5 weeks after PCA training, and were subsequently used for ex vivo measurement of 
stimulated DA release using fast-scan cyclic voltammetry (FSCV). ST and GT rats were 
sacrificed via rapid decapitation and brains were immediately extracted. 400µm-thick 
coronal slices of brain tissue were collected and bathed in oxygenated artificial cerebral 
spinal fluid (aCSF) at 32°C. During FSCV, a glass-encased carbon fiber microelectrode 
was lowered into the NAc core. Calibration of the carbon fiber FSCV electrode allows 
for current measurements to be converted to DA concentration ([DA]; 1.9-5.5 nA/µM 
DA). A bipolar stimulating electrode was placed nearby and positioned to evoke 
optimal DA release. Following stabilization, alternating 1-pulse (300µA, 4ms) and 5-
pulse (300µA, 20Hz) electrical stimulations were delivered to the slice, once every 5-
minutes. Since both stimulations resulted in similar DA responses, and because the 
kinetics of 1-pulse stimulations may be more accurately modeled using Michaelis–
Menten parameters, only the 1-pulse stimulation data are presented in the results. 
Current changes recorded on the electrode are shown and plotted against the applied 
voltage (Eapp) and time. The holding potential applied to the carbon-fiber electrode (-
0.4 V) was ramped to +1.3 V and back to -0.4 V at a rate of 10 Hz.  
Following stimulation, the peak [DA] represents the total amount of DA released 
into the extracellular space ([DA]c). This measurement, calculated at the peak [DA] 
following stimulation, may be impacted by differences in both DA release and uptake 
(Wightman et al., 1988; Wu et al., 2001; Ramsson, Howard, et al., 2011), and therefore 
was modeled using Michaelis–Menten parameters, with the help of Demon 
Voltammetry software provided courtesy of Dr. Sara R. Jones at Wake Forest University 
(Yorgason et al., 2011). DA uptake was quantified using Vmax and the apparent Km. Vmax, 
the maximum speed of DA uptake ([DA] per second), is associated with DAT surface 
expression and turnover. Km is inversely related to the affinity for DA to bind DAT. As 
has been described elsewhere (Wu et al., 2001; Calipari et al., 2015), at baseline Km was 
set to 160 nM and Vmax was calculated as a value of DA uptake. In order to determine 
the amount of DA released per single stimulation pulse ([DA]p), the amount of DA 
removed by uptake (calculated using Vmax and Km values) was subtracted from [DA]c 
following stimulation, using Demon Voltammetry.  
 
Tissue DA Content 
 Ventral striatal dopamine content was analyzed 3 weeks after cessation of 
conditioning. STs and GTs (n=6/group) were sacrificed via rapid decapitation. Brains 
were removed quickly and the ventral striatum was dissected on ice. Synaptosomes 
were then prepared and dopamine content was analyzed as described previously 
(Johnson et al., 2005; Chen et al., 2009). Briefly, bilateral tissue from single rats were first 
homogenized in 0.32 M sucrose containing 1 mM EDTA and Complete Mini protease 
inhibitor cocktail (Roche, Basel, Switzerland). Homogenates were then centrifuged at 
4 °C (800 × g, 10 min) to remove cellular debris. The supernatant was next centrifuged 
again (12,000 × g, 15 min, 4 °C) and the pellet was used as crude synaptosomes. The 
pellet containing crude synaptosomes was resuspended in 100 µl of oxygenated Kreb-




, 1.0 mM MgCl
2
, 
10 mM glucose, 24.9 mM NaHCO
3
, 0.05 mM ascorbic acid, 0.05 mM pargyline, pH 7.4). 
Synaptosomes (10 µl) were lysed using an internal standard solution composed of 
50 mM perchloric acid, 25 µM EDTA, and 10 nM 2-aminophenol. Samples were diluted 
in KRB. Dopamine content in each sample was measured using high-performance 
liquid chromatography (HPLC) with electrochemical detection. 
 
DAT Expression 
After having been left undisturbed in their home cages for 3-5 weeks, rats [ST 
(n=30) and GT (n=22)] were rapidly decapitated and brains were harvested for 
measurement of DAT surface expression in synaptosomes. On ice, bilateral ventral 
striatal tissue (including the NAc core and shell) was obtained through hand-dissection. 
Due to low levels of DAT expression in the ventral striatum, each sample contained 
tissue pooled from 2-4 rats with similar PCA scores (ST, 10 samples; GT, 8 samples). On 
average, the difference between the strongest and weakest ST/GT in each pooled sample 
was a PCA index of 0.11 ± 0.046.  
Synaptosome preparation was conducted as described above. Synaptosomal 
membrane proteins were subsequently biotinylated with 2 mg/ml sulfo-NHS-SS-biotin 
(Thermo Scientific, Waltham, MA, USA) in PBS/Ca-Mg (1 mM CaCl2 and MgCl2) 
overnight at 4 °C. Afterward, the biotinylation reaction was quenched by adding 100 
mM glycine and incubating for 15 min. Synaptosomes were then washed twice with 100 
mM glycine in PBS/Ca-Mg and subsequently lysed in RIPAE buffer (10 mM Tris, pH 
7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X 100 and Complete Mini Protease inhibitor; 
Roche, Basel, Switzerland) for 1 hr at 4 °C. The obtained lysate was cleared by 
centrifugation at 20,000 g for 20 min at 4 °C and measured for protein concentration 
using a Bio-Rad Dc protein assay kit (Hercules, CA, USA). Samples (1 mg) were 
incubated with monomeric avidin beads (50 µl) overnight at 4 °C. The next day the 
beads were washed three times with RIPAE buffer and eluted in 2 X Laemmli sample 
buffer. The eluates and 50 µg of total synaptosomal lysate were resolved by SDS-PAGE 
(10% Tris-glycine) and immunoblotted using anti-DAT antibody (mouse monoclonal; 
1:500 in 5% milk in TBST (Tris buffered saline with 0.05% Tween 20); courtesy of Dr. 
Vaughan, Department of Biochemistry, University of Nebraska) followed by 
horseradish peroxidase-conjugated secondary antibody (goat anti-mouse, SC-2055, 
RRID: AB 631738; 1:2000 in 5% milk in TBST; Santa Cruz Biotechnology, Dallas, TX, 
USA) and detected with enhanced chemiluminiscence reagent (Pierce, Thermo 
Scientific, Waltham, MA, USA). 
 
Experiment 2: DA Response to AMPH 
ST (n= 6) and GT (n=7) rats were left undisturbed in their home cages for 3-9 
weeks. After induction of anesthesia (urethane, 1.5 g/kg, IP), a guide cannula 
(Bioanalytical Systems, West Lafayette, IN) was implanted dorsal to the NAc core (AP, 
+1.3; ML, ±1.3; DV, -2.5 mm relative to bregma) and an Ag/AgCl reference electrode was 
secured in the contralateral cortex (AP, -0.8; ML, ±4.0; DV, -2.0 mm relative to bregma). 
A bipolar stimulating electrode (AP, -5.2; ML, ±0.8 mm relative to bregma; Plastics One, 
Roanoke, VA) was lowered into the ventral tegmental area (VTA) until electrically-
evoked DA release was able to be measured in the striatum, as previously described 
(Vander Weele et al., 2014). DA release was recorded using glass-encased cylindrical 
carbon-fiber electrodes. FSCV relied on the oxidation and reduction of the analyte of 
interest (i.e. DA) in response to the application of a triangular waveform (oxidative 
scan, -0.4 to 1.3 V; reductive scan, 1.3 V to -0.4 V; 400V/s). This waveform was cycled for 
20 min at 60 Hz, followed by another 20 min at 10 Hz.  
After the bipolar stimulating electrode was lowered into the VTA and cemented 
in place, stimulations of the VTA (60 Hz, 40 pulse) were applied once every 10 minutes 
until a stable DA response in the NAc core was achieved. Rats then received a saline 
injection (1 ml/kg, IP) followed by an AMPH injection (5 mg/kg, IP) 40 minutes later. 
VTA stimulations continued throughout this period, and finished 40 minutes after the 
final post-drug stimulation. At that time, rats were sacrificed via sodium pentobarbital 
overdose (60 mg/kg, IP) and electrolytic lesions (tungsten electrodes, 20 µA for 15 s) of 
the recording site were made. Brains were then removed and sliced to confirm NAc 
core electrode placements. Data were recorded for 40 minutes after AMPH 
administration in order to mirror the amount of time of a single conditioning session. 
Analysis of stimulated DA release and uptake was performed using Demon 
Voltammetry software, in a similar fashion to Experiment 1. Vmax (the speed of DA 
uptake), Km (the ability of the treatment to inhibit DA uptake), and [DA]p (the ability of 
a single stimulation to evoke DA release) were first analyzed following the saline 
injection. The Vmax value determined for each rat following saline was then held 
constant when analyzing post-AMPH data, allowing for drug-induced changes in both 
Km and [DA]p to be modeled (Ramsson, Covey, et al., 2011; Daberkow et al., 2013; 
Calipari et al., 2015). “Fixing” Vmax at pre-drug levels is used because, as a competitive 
inhibitor of DA uptake at DATs, AMPH does not alter Vmax (Jones et al., 1999; Schmitz et 
al., 2001; John & Jones, 2007; Ramsson, Covey, et al., 2011; Ferris et al., 2015). Although 
AMPH has been reported to alter surface DAT in vitro (Zahniser & Sorkin, 2009), a 
recent study found that administration of AMPH in vivo or to striatal slices did not 
change DAT distribution (Block et al., 2015). Due to individual variation in the DA 
responses following both saline and AMPH, calculations of Km, [DA]p, and [DA]c were 
analyzed as a percent change from saline measurements.  
 
Experiment 3: Behavioral Response to AMPH 
A subset of ST/GT rats underwent stereotaxic surgery for implantation of chronic 
22 gauge bilateral guide cannulae (Plastics One) aimed at the NAc core (A/P, +1.8; M/L, 
±1.6; D/V, -5; mm from bregma and skull), as described previously (Saunders et al., 2013; 
Singer et al., 2014). After 1-week recovery from surgery, rats underwent 2 additional 
days of PCA training to confirm that conditioned responding was consistent with pre-
surgical behavior. 
The experiment assessed the effect of bilateral (2, 10, or 20µg; Wyvell and 
Berridge, 2000) microinjections of AMPH into the NAc core on PCA. On the first testing 
day all rats received saline (vehicle) microinjections. Thereafter, once every third day 
rats received an AMPH microinjection. The order in which doses were administered 
was counterbalanced across rats. After microinjection, rats were returned to their home 
cages for 15 minutes before being transported to operant chambers for PCA assessment. 
Rats then completed 25 conditioning trials using identical procedures as during initial 
PCA training. Rats were left undisturbed on days between microinjections. At the 
conclusion of experiment rats were deeply anaesthetized (sodium pentobarbital; 60 
mg/kg, IP), brains were removed, and coronal brain sections were obtained to verify 
cannula tip placements. Only rats with bilateral cannula tips placed correctly in the 
NAc core were included in the behavioral analyses. 
 
Statistical Analyses 
 For initial Pavlovian training, independent t-tests were used to analyze the 
number of food cup contacts during inter-stimulus-intervals in ST and GT rats. 
Independent t-tests were also used to analyze all voltammetry ([DA]c, [DA]p, and 
Vmax) and DAT expression results described in Experiment 1. For Experiment 2, the 
effect of AMPH on stimulated DA release and uptake ([DA]c, [DA]p, and Km) was 
analyzed using repeated measures ANOVAs, with group (ST or GT) as the between 
factor and time after AMPH (treatment) as the within-factor. Post hoc Bonferroni 
tests were used to determine group differences at each post-injection time point. 
Similar statistical procedures were used in Experiment 2; a repeated measures 
ANOVA was used to determine the effect of multiple doses of AMPH on lever (ST) 
and food cup (GT) contacts. For this analysis, behavioral group (ST/GT) was the 
between factor and AMPH dose was the within-factor. Again, Bonferroni tests were 
used to assess whether AMPH caused different dose-specific responses in STs and 
GTs. Next, separate 1-way ANOVAs were conducted to analyze ST and GT 
conditioned response contacts after AMPH, relative to vehicle. Bonferroni tests were 




As described previously (Flagel et al., 2007; Robinson et al., 2014), patterns of 
conditioned responding were measured in order to identify sub-populations of rats. 
Over the course of 5 training days, STs increasingly made contact with the lever CS, 
whereas GTs failed to engage in this behavior (Figure 1A; STs, PCA index +1.0 to +0.4, 
38% of rats trained; GTs, PCA index -0.4 to -1.0, 36% of rats trained). Rather, GTs 
showed increased food cup contacts (i.e., the CR characteristic of this sub-population) 
while STs showed decreases in this behavior (Figure 1B). Additionally, similar to a 
previous report (Meyer et al., 2012), GTs tended to contact the food cup more during 
inter-stimulus-intervals than STs (t97=1.868, p=0.0765). Although “intermediate” rats 
were classified (neither ST nor GT, PCA score -0.4 to +0.4), they were not used in the 
present experiments because we wanted to compare rats that differed maximally in 
their propensity to attribute incentive salience to reward cues; i.e., STs and GTs. 
 
Experiment 1: Presynaptic Regulation of DA Signaling in the NAc core 
 FSCV was used to determine whether STs and GTs displayed differences in DA 
release and/or uptake capability (Figure 2). Representative color plots (Figure 2A,B) and 
mean [DA] traces (Figure 2C,D) show that, following electrical stimulation, GTs had 
greater extracellular DA and slower DA uptake than STs. Quantification of these data 
demonstrate that the peak stimulated [DA]c was indeed greater for GTs than STs 
(Figure 2E; t9=2.559, *p=0.0307). Despite GTs showing greater extracellular DA than STs, 
GTs and STs did not differ in the amount of DA released per stimulation pulse ([DA]p; 
Figure 2F; t9=0.04010, p=0.9689, ns). Furthermore, STs and GTs did not differ in the total 
content of DA in synaptosomes prepared from ventral striatal tissue (Figure 2G; 
t10=0.7880, p=0.4490, ns). While there is need for further investigation, these latter 
findings suggest that STs and GTs may have the same amount of ventral striatal DA 
available for release. 
 A key factor that contributes to [DA]c levels following stimulation is DA uptake 
(Wightman et al., 1988; Wu et al., 2001; Ramsson, Howard, et al., 2011). Therefore, the 
speed of DA uptake (Vmax) in STs and GTs was investigated (Figure 2H). Relative to 
GTs, STs displayed faster clearance of extracellular DA in the NAc core (t9=2.616, 
*p=0.0280). Together, these findings suggest that, compared to STs, greater stimulated 
[DA]c in GTs (Figure 2E) results from relatively slow DA uptake, and not from 
differences in their ability to release DA ([DA]p). In other words, faster DA uptake in 
STs restricts the ability of electrical stimulation to increase [DA]c. 
Increased speed of DA uptake in STs may reflect greater DAT expression 
compared to GTs. This was examined by measuring DAT expression in synaptosomes 
prepared from ventral striatal tissue. Indeed, we found that STs had greater surface 
expression of DATs than GTs (t16=2.718, *p=0.0152; Figure 3A), although, there was no 
difference between STs and GTs in total DAT expression in synaptosomal lysates 
(t16=1.386, p=0.1848, ns; Figure 3B). Thus, greater DAT surface expression in STs may 
account for greater DA uptake in STs following ex vivo stimulation of terminals. 
 
Experiment 2: DA Response to AMPH 
 Since 1) STs have more functional surface DATs than GTs, and 2) AMPH 
promotes increases in extracellular [DA] through binding to and reversal of DATs, we 
hypothesized that STs would also show a greater reduction in DA uptake following 
AMPH than GTs. To test this, urethane-anesthetized rats were first administered saline 
and then AMPH, and [DA] changes in the NAc core produced by electrical stimulation 
of the VTA were quantified. Representative color plots (Figure 4A,B) and mean peak-
normalized [DA] traces (Figure 4C) show that, 30 minutes after AMPH administration, 
there was greater inhibition of DA uptake in STs than GTs compared to baseline (saline) 
conditions.  
Differences in DA uptake following AMPH, relative to saline, were determined 
from apparent Km values calculated using Michaelis-Menten modeling. Increases in Km 
values after AMPH represent enhanced inhibition of DA uptake. As expected, systemic 
AMPH injection reduced DA uptake in both STs and GTs (Figure 4D; time effect 
F4,44=19.43, ***p=0.0001). However, AMPH produced greater inhibition of DA uptake in 
STs than in GTs (group effect, F1,11=6.55, *p=0.0266; group x time interaction, F4,44=3.81, 
**p=0.0097). Bonferroni tests revealed that this reduction in uptake in STs progressed 
over time, reaching significant difference from GTs by 30 minutes post-injection. These 
data suggest that greater DAT surface expression in STs than in GTs may facilitate the 
ability of AMPH to inhibit DA uptake in STs. 
In addition to reducing DA uptake, AMPH also increases synaptic DA levels by 
promoting vesicular release and efflux through DATs. As measured at the peak [DA] in 
the NAc core following VTA stimulation, AMPH enhanced the ability of stimulation to 
increase extracellular DA levels in both ST and GT rats ([DA]c time effect, F4,44=5.52, 
**p=0.0011; data not shown). Since changes in peak [DA]c may reflect both DA release 
and uptake (Wightman et al., 1988; Wu et al., 2001; Ramsson, Howard, et al., 2011), 
Michaelis-Menten modeling was used to determine the ability of AMPH to enhance DA 
release following a single electrical pulse ([DA]p). AMPH enhanced [DA]p responses in 
both STs and GTs (Figure 4D; [DA]p time effect, F4,44=3.25, *p=0.0201). Interestingly, 
relative to saline, there was no difference between STs and GTs in either [DA]c (group 
effect, F1,11=1.03, p=0.3315, ns; group X treatment interaction, F4,44=0.73, p=0.5762, ns) or 
[DA]p (group effect, F1,11=1.26, p=0.2864, ns; group X treatment interaction, F4,44=0.57, 
p=0.6872, ns).  
We found this surprising, because greater inhibition of DA uptake after AMPH 
in STs than GTs would be expected to result in greater [DA]c, even if [DA]p were not 
changed. It is possible that inhibition of DA uptake by AMPH does not contribute to 
[DA]c. [DA]c is an instantaneous measurement taken at the peak [DA] following 
stimulation. Thus, [DA]c is not a measurement of the long-lasting tonic increase of DA 
in the synapse following stimulation, an effect that is exaggerated by AMPH to a 
greater degree in STs than in GTs. In addition, while NAc core DA responses measured 
using FSCV following electrical stimulation of the VTA allow for detection of 
differences in vesicular release, and for quantifying differences in reuptake, this 
technique may not be suitable for determining differences in DA efflux resulting from 
the depletion of vesicular stores and reversal of DATs produced by AMPH (Ramsson, 
Howard, et al., 2011). Furthermore, AMPH may enhance DA release through 
mechanisms that do not involve DATs (Dela Peña et al., 2015). Alternatively, the lack of 
a ST/GT difference in [DA]c and [DA]p may indicate a “ceiling effect”. This dose of 
AMPH would produce an extremely large and non-physiological increase in [DA] 
(Camp et al., 1994), and the combination of stimulation parameters and AMPH dose 
may result in a maximal amount of DA being released. Indeed, STs and GTs have 
similar synaptosomal DA levels in the ventral striatum (Figure 2G), as well as ability to 
release DA in the NAc core (Figure 2F).  
 
Experiment 3: Behavioral Response to AMPH 
Given the ability of AMPH to reduce DA uptake to a greater degree in STs than 
in GTs, we next wanted to determine if this might have a functional consequence at the 
behavioral level. Thus, we examined the effect of an injection of AMPH into the NAc 
core on ‘contacts’ with either the lever (STs) or food cup (GTs) during performance on 
the PCA task. As expected, control infusions (saline) into the NAc core had no impact 
on the number of contacts made (Figure 5A). However, AMPH produced a dose-
dependent increase in lever contacts made by STs. This robust increase was detected 
using a 2-way repeated measures ANOVA (group effect, F1,9=27.82, ***p=0.0005; 
treatment effect, F3,27=3.14, *p=0.0416; treatment X group interaction, F3,27=3.48, 
*p=0.0296). STs showed a greater increase in contacts at all doses tested compared to 
GTs (*p<0.01-0.05, Bonferroni tests). To better understand this change and demonstrate 
how conditioned responding compared to vehicle, STs and GTs were analyzed 
separately using 1-way ANOVAs. Indeed, AMPH microinjections significantly 
increased lever contacts in STs (F3,20=4.615, *p=0.0130) at both 10 and 20 µg doses of 
AMPH (*p<0.05, Bonferroni tests). In contrast, AMPH did not affect the number of food 
cup contacts made by GTs (one-way ANOVA, F3,16=1.117, p=0.3713, ns). Finally, AMPH 
had no effect of food cup contacts in STs (one-way ANOVA, F3,20=2.373, p=0.1007, ns) or 
lever presses in GTs (one-way ANOVA, F3,16=0.5294, p=0.6685, ns) during the CS period. 
Therefore, the effect of AMPH was not to increase sign-tracking in every rat, but only in 
rats that already attributed incentive salience to the cue (STs). While we hypothesize 
this may be due to the ability of AMPH to inhibit DA uptake in the NAc core to a 
greater degree in STs than in GTs, this interpretation may be complicated by the 
different routes of drug administration (IP vs intra-NAc).   
 STs may have engaged with the lever more because AMPH enhanced non-
specific motor output to a greater degree in STs (Fletcher et al., 1998). If this were the 
case one might expect an increase in food cup contacts during inter-stimulus-intervals. 
However, AMPH had no effect on food cup contacts during inter-stimulus-intervals in 
either STs or GTs (treatment effect, F3,27=0.08, p=0.9723, ns; group effect, F1,9=2.12, 
p=0.1795, ns; group X treatment interaction, F3,27=0.93, p=0.4408, ns; data expressed as % 
control; data not shown). We hypothesize, therefore, that increased lever contacts in STs 
reflects the ability of AMPH to amplify the incentive properties of the CS (Wyvell & 
Berridge, 2000), and it appears to do so preferentially in rats that already attribute 
incentive salience to the CS (STs). 
 
Discussion 
There is considerable individual variation in the extent to which predictive 
reward cues are attributed with incentive salience, in both humans and non-human 
animals (Mahler & de Wit, 2010; Robinson et al., 2014; Garofalo & di Pellegrino, 2015). 
For some rats (STs) discrete reward cues elicit approach into close proximity with them, 
and they work avidly to get them. In contrast, other rats (GTs) attribute less incentive 
value to discrete CSs, approaching the location of reward delivery instead of the CS 
itself, and they work less avidly for them. Previous studies have shown that DA 
transmission in the NAc core is more important for both the acquisition (Flagel et al., 
2011) and performance (Saunders & Robinson, 2012) of ST than GT CRs. Here we 
further extend our understanding of how variation in the dopaminergic system may 
contribute to variation in the motivational control over behavior by reward cues.  
Microinfusion of AMPH into the NAc core of STs increased the vigor with which 
they interacted with the lever-CS, without influencing conditioned behavior in GTs. 
This difference may be related to variation in the effect of AMPH on DA 
neurotransmission, as AMPH produced greater inhibition of DA uptake in STs than in 
GTs. In addition, STs had greater DAT surface expression in ventral striatal 
synaptosomes than GTs. In summary, the present results further support the idea that 
variation in DA neurotransmission may contribute to variation in the propensity to 
attribute incentive salience to reward cues (Flagel et al., 2011; Robinson et al., 2014), and 
in particular, STs and GTs vary in the expression and function of the DAT in the ventral 
striatum.  
 
Behavioral Response to AMPH 
Several studies have shown that inhibiting DA signaling by using DA 
antagonists, given either systemically (Danna and Elmer, 2010) or just in the NAc core 
(Saunders and Robinson, 2012; Yager et al., 2015), decreases sign-tracking, but not goal-
tracking. Conversely, a lesion of the habenula, which is thought to disinhibit VTA DA 
neurons and lead to greater DA neurotransmission, enhances sign-tracking, but not 
goal-tracking (Danna et al., 2013). Infusion of psychostimulants directly into the NAc 
increases [DA]c (Heidbreder & Feldon, 1998), conditioned motivation (Wyvell & 
Berridge, 2000; Peciña & Berridge, 2013), and conditioned reinforcement (Fletcher et al., 
1998). In STs, AMPH injected into the NAc core facilitates discrete cue-evoked drug 
seeking (Saunders et al., 2013). Consistent with this, the present results provide the first 
evidence that an AMPH injection into the NAc core is sufficient to facilitate sign-
tracking (but not goal-tracking), presumably because of its ability to preferentially 
inhibit DA uptake in STs. 
 
DA Signaling 
The ex vivo FSCV results indicated greater clearance of DA in STs compared to 
GTs, potentially a reflection of increased DAT surface expression in STs. It is possible 
that in STs greater control over DA overflow could allow for more precise time-locked 
DA release events during CS presentation, influencing lever approach (Flagel et al., 
2011). Indeed, the temporal precision of DA signaling may be very important to the 
encoding of information regarding salient stimuli (Wieland et al., 2015). Furthermore, 
low doses of AMPH may enhance CS-evoked [DA]c (Daberkow et al., 2013) and AMPH 
can increase [DA]c through inhibition of DAT alone (Siciliano et al., 2014). While the 
dose of AMPH used may have been too high to detect ST/GT differences in [DA]c 
(Camp et al., 1994), AMPH also did not produce differential effects on stimulated 
release ([DA]p). We therefore hypothesize that, under more physiological conditions, 
enhanced inhibition of DA uptake in STs (Km) following AMPH may allow the CS to 
elevate [DA]c to a greater degree than in GTs, enhancing conditioned approach. 
In contrast, slower DA uptake in GTs is consistent with results from DAT knock-
down (KD) or knock-out mice (Giros et al., 1996; Zhuang et al., 2001). Interestingly, both 
GTs (Meyer et al., 2012) and DAT KD mice (Yin et al., 2006) show increased food cup 
contacts during inter-stimulus-intervals. Thus, relative to STs, lower DAT surface 
expression in GTs may degrade the temporal control CSs exert over behavior. It is 
possible that reduced DAT expression may help elevate “tonic” levels of ventral striatal 
DA in GTs, potentially enhancing the probability of them entering the food cup during 
inter-stimulus-intervals. Alternatively, lower DAT surface expression in GTs may 
support different forms of conditioned responding compared to STs. For example, 
unlike STs who attribute incentive value to discrete CS, GTs are more motivated by 
contextual CSs (Saunders et al., 2014). It is possible that lower DAT expression in GTs 
results in greater “tonic” DA levels in the NAc compared to STs, and this different 
modality of DA signaling may more readily support contextual conditioning. 
In brain slices, stimulation-evoked [DA]c was greater in GTs than STs. However, 
there were no group differences in total synaptosomal tissue [DA] content between STs 
and GTs, nor in the amount of DA released per stimulation pulse ([DA]p) in either brain 
slices or in urethane-anesthetized rats, before or after AMPH. It seems unlikely, 
therefore, that STs and GTs simply differ in the amount of DA available for release. 
Instead, the greater peak evoked [DA]c seen in slices may reflect reduced availability of 
(i.e. saturated) DAT binding in GTs (Wightman et al., 1988; Wu et al., 2001; Garris et al., 
2003; Ramsson, Howard, et al., 2011). Of course there are other modulators of DA 
transmission that could contribute and require investigation (Garris et al., 2003; Zhang 
et al., 2009; Melchior et al., 2015).  
DAT Expression  
Greater surface DAT in STs may provide more binding sites for AMPH, 
potentially leading to exaggerated DA responses (Calipari et al., 2015). It is 
hypothesized that this drug-induced reduction in DA uptake contributes to the increase 
in sign-tracking behavior observed. Furthermore, AMPH microinjected into the NAc 
core also increases conditioned motivation to a greater degree in STs than in GTs 
(Saunders et al., 2013). Thus, greater DAT surface expression in STs may facilitate the 
ability of AMPH to enhance the incentive value of CSs.   
Given that STs and GTs have similar total DAT levels, it is possible that these rats 
differ in the ability to traffic and retain DAT on the synaptic membrane. Increased DAT 
surface expression could reflect differential activation of proteins that regulate DAT 
trafficking, including PKCβ (Chen et al., 2009). In addition, STs and GTs could also 
differ in movement of DAT into and out of the membrane after administration of 
AMPH (Johnson et al., 2005; Yamamoto et al., 2013). However, a single AMPH injection 
does not alter the maximal rate of DA uptake (Vmax, a measure of DAT expression) 
within 1 hour of administration (Ferris et al., 2015). It remains to be explored whether 
psychostimulant exposure differently alters DAT expression in STs and GTs.  
One caveat to the interpretation of the present findings is that it is not possible to 
tell if ST/GT differences in DAT expression and function are constitutive, as we 
hypothesize, or are a result of the initial training experience used to identify the 
phenotypes. DAT measures were obtained at different time-points weeks after training 
in an attempt to decrease any recent learning effects. Furthermore, it seems unlikely any 
such memories would be represented by a change in DAT, especially since in humans 
constitutive upregulation of DAT due to genetics also influences attraction to cues 
(Erblich et al., 2005; van Dyck et al., 2005). Even if DAT surface expression is not 
elevated before conditioning in STs, it is still likely that their neurophysiology supports 
up-regulation. Future experiments using micro positron emission tomography imaging 
of DAT expression in rats before conditioning may address this question. 
 
Conclusion 
Tight regulation over DA signaling in the NAc by DATs may facilitate the 
attribution of incentive salience to the reward-paired CS. Compared to GTs, 
upregulation of DAT surface expression and function in STs may enhance the ability of 
AMPH to increase DA signaling in the NAc and amplify sign-tracking. AMPH had no 
effect on conditioned approach in GTs, and thus presumably did not enhance the 
incentive value of the lever-CS in GTs. Importantly, individual variation in DAT 
expression may also produce differences in attraction to reward paired cues in humans. 
People with a variable number of tandem repeat (VNTR) polymorphism in the DAT 
gene (SLC6A3; 9-repeat allele) show greater cue-induced cigarette cravings than non-
carriers (Vandenbergh et al., 1992; Erblich et al., 2005; Wetherill et al., 2014). These 
individuals show enhanced ventral striatal activation to nicotine cues (Franklin et al., 
2009, 2011) and elevated smoking-induced DA signaling in the NAc (Brody et al., 2006). 
Furthermore, healthy adults with this polymorphism show greater striatal DAT 
expression compared to other individuals (Jacobsen et al., 2000; van Dyck et al., 2005; 
van de Giessen et al., 2009; but see the following references, Heinz et al., 2000; Martinez 
et al., 2001; Lynch et al., 2003). Therefore, both ST rats and people with the 9-repeat 
SLC6A3 polymorphism exhibit greater DAT expression and attraction to reward-paired 
cues relative to GTs and non-carriers, respectively. These findings thus support 
translational research using variation in Pavlovian conditioned approach behavior to 
investigate how DAT function contributes to addiction. 
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Figure 1. Conditioned approach.  
For all rats tested, average lever-contacts (“sign-tracking,” ST, PCA Index +0.4 to +1.0, 
n=54; A) and food cup contacts (“goal-tracking,” GT, PCA Index -0.4 to -1.0, n=45; B) 
across 5 training days.  
 
Figure 2. DA signaling. 
DA release evoked by electrical stimulation of the NAc core was recorded using ex vivo 
FSCV. Representative color plots from a single 1-pulse stimulation are shown for a GT 
(A) and ST (B) rat. Stimulation occurred at 5-s into the recording. Plots show current 
changes recorded on the electrode, plotted against the applied voltage (Eapp) and time. 
The holding potential applied to the carbon-fiber electrode (-0.4 V) was ramped to +1.3 
V and back to -0.4 V at a rate of 10 Hz. Cyclic voltammograms plotting current versus 
voltage at the peak DA response are shown in white. (C) Calibrated average [DA] traces 
for GT (n=5) and ST (n=6) rats following 1-pulse stimulation are shown. (D) In order to 
better illustrate differences in DA uptake between STs and GTs, the average [DA] traces 
in (C) were normalized to peak height following stimulation. The resulting [DA] traces 
show that STs return to baseline faster than GTs. (E) GTs displayed significantly greater 
peak stimulated [DA]c compared to ST (p<0.05). There were no significant differences in 
either the amount of DA released per stimulation pulse (F; [DA]p) or in total tissue [DA] 
measured in ventral striatal synaptosomes using HPLC (G). (H) STs displayed 
significantly faster DA uptake relative to GTs following electrical stimulation (*p<0.05). 
Results plotted as mean ± SEM. 
 
Figure 3. DAT expression.  
DAT expression was assessed in ventral striatal synaptosomes (ST, n=10; GT, n=8). (A) 
STs displayed greater DAT surface expression (biotinylated/lysate) compared to GTs 
(*p<0.05). (B) There was no difference in total (lysate) DAT expression. Representative 
western blots showing DAT expression are displayed below graphs. The green-shaded 
region on the drawing of a coronal brain section (adapted from Paxinos and Watson 
2004) shows the region dissected for DAT measurements. Results plotted as mean ± 
SEM. 
 
Figure 4. The influence of AMPH on electrically-stimulated release and uptake. 
In urethane-anesthetized rats (ST, n=6; GT, n=7), the VTA was stimulated (60Hz/40-
pulse biphasic) every 10 min and [DA] in the NAc core was recorded using FSCV 
following saline (1 ml/kg, IP) and AMPH (5 mg/kg, IP) injections. Representative color 
plots from single GT (A) and ST (B) rats, showing stimulated DA release 30-min after 
saline (top) and AMPH (bottom) injections. Stimulation occurred at 5-s into the 
recording and plots show current changes recorded on the electrode, plotted against the 
applied voltage (Eapp) and time. Cyclic voltammograms plotting current versus voltage 
at the peak DA response are shown in white. (C) Average stimulated [DA] traces 
(normalized to peak height) are shown at both 30-min post-saline and post-AMPH 
time-points for STs and GTs. While AMPH slowed uptake in both STs and GTs, the 
effect was exaggerated in STs since they had faster DA uptake under predrug 
conditions. These effects were analyzed in (D), where Vmax was held constant according 
to saline values and the “apparent” (app.) Km was used to determine AMPH-induced 
changes in DA uptake inhibition. While AMPH increased the app. Km in both STs and 
GTs (‡‡‡, p<0.001), this increase was significantly greater in STs than GTs at 30- and 40-
minutes post-drug (*, p<0.05). In addition, the amount of DA release after stimulation 
([DA]p) was enhanced after AMPH compared to saline (#, p<0.05), but did not differ 
between STs and GTs. Data are shown as means (±SEM).   
 
Figure 5. AMPH amplifies conditioned approach in STs. 
(A) After training, a subset of rats received saline and AMPH microinjections into the 
NAc core, 15 min before additional conditioning sessions (ST, n=6; GT, n=5). Data are 
plotted as percent behavioral changes relative to vehicle (saline, veh) infusion for lever 
contacts (STs) or food cup contacts (GTs). Relative to GTs, in STs AMPH increased 
conditioned approach at all doses tested (###, p<0.001). More specifically, both 10 & 20 
µg of AMPH significantly increased lever contacts in STs (*, p<0.05) compared to their 
response to vehicle. AMPH had no effect on lever contacts in GTs or food cup contacts 
in STs (data not shown). (B) Microinjection locations in the NAc core for STs (red) and 
GTs (blue) (adapted from Paxinos and Watson 2004). Results plotted as mean ± SEM. 
